Validation of the ICH Score for the Prediction of 12-month Functional Outcome in Patients With Primary Intracerebral Hemorrhage

National Taiwan University

Status: Completed

Conditions: Intra Cerebral Hemorrhage

Treatments: Other: Phone interview

Study type: Observational

Funder types: Other

Identifiers

NCT05808777

201905045RINB

Details and patient eligibility

About

The goal of this observational study is to analyze the validity of the intracerebral hemorrhage (ICH) Score and a new modified ICH score for the prediction of 12-month functional outcome in patients with primary ICH.

Participants who were admitted to NTUH rehabilitation ward will be followed up to 12 months after the onset of ICH. The follow-up will be conducted by phone interviews.

Full description

The ICH Score had been utilized to predict the 30-day mortality after acute intracerebral hemorrhage (ICH), but there's still no reliable tool in predicting the long-term functional outcome in ICH patients. Recently, there have been some studies that use ICH score to predict the prognosis of functional outcome in ICH patients. However, most studies included patients in western societies. Relevant studies in Taiwan were scarce. The present study will follow up the patients with ICH, who were admitted to NTUH rehabilitation ward, up to 12 months post stroke. The follow-up will be conducted by phone interviews at certain time after the onset of ICH. Investigators aim to analyze the validity of the ICH Score for the prediction of 12-month functional outcome in patients with primary ICH. Investigators will also add other variables to see if the revised score could better predict the prognosis among ICH patients.

Enrollment: 100 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged 20 years or older
• Had been admitted to a neurology, neurosurgery, or rehabilitation ward with a diagnosis of primary intracerebral hemorrhage (ICH)
• Had a diagnosis of ICH confirmed by a brain computed tomography (CT)
• Have written informed consent given by themselves or by their legal representative

Exclusion criteria

• ICH related to aneurysm, arteriovenous malformation, or trauma
• Died before discharge

Trial design

100 participants in 1 patient group

ICH

Description:

Patients were eligible for inclusion if they 1. were aged 20 years or older 2. had been admitted to a neurology, neurosurgery, or rehabilitation ward with a diagnosis of primary ICH 3. had a diagnosis of ICH confirmed by a brain CT 4. have written informed consent given by themselves or by their legal representative

Treatment:

Other: Phone interview